Seth Klarman · Q4 2017
Baupost Group
Portfolio at the end of Q4 2017, from the 13F filed February 13, 2018. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Synchrony SYF · history | 11.2% | Q3 2016 | No change |
| Cheniere Energy LNG · history | 11.0% | Q1 2014 | No change |
| Viasat VSAT · history | 9.7% | Q2 2013 or earlier | No change |
| Twenty-First Century Fox FOXA · history | 7.6% | Q3 2015 | Add 16% |
| Time Warner TWX · history | 7.3% | Q4 2017 | Buy |
| Allergan AGN · history | 7.3% | Q1 2016 | Add 52% |
| Qorvo QRVO · history | 7.2% | Q1 2017 | Add 22% |
| Colony NorthStar CLNS · history | 5.4% | Q1 2017 | No change |
| Antero Resources AR · history | 4.6% | Q3 2014 | Add 3% |
| PBF Energy PBF · history | 3.8% | Q3 2013 | Reduce 31% |
| Twenty-First Century Fox FOX · history | 3.6% | Q3 2015 | Add 43% |
| Pioneer Natural Resources PXD · history | 3.4% | Q3 2017 | Add 6822% |
| Cardinal Health CAH · history | 3.1% | Q4 2016 | Add 102% |
| Theravance Biopharma TBPH · history | 2.6% | Q2 2014 | No change |
| McKesson MCK · history | 2.1% | Q3 2017 | Add 172% |
| Express Scripts ESRX · history | 1.7% | Q1 2017 | Reduce 10% |
| Cencora COR · history | 1.3% | Q3 2017 | Add 660% |
| Keryx Biopharmaceuticals KERX · history | 1.2% | Q1 2014 | No change |
| Veritiv VRTV · history | 1.0% | Q3 2014 | Add 19% |
| Atara Biotherapeutics ATRA · history | 1.0% | Q4 2014 | No change |
| AMC Entertainment AMC · history | 0.7% | Q3 2017 | Add 40% |
| GTY Technology GTYH.U · units · history | 0.4% | Q4 2016 | No change |
| Paratek Pharmaceuticals PRTK · history | 0.4% | Q4 2014 | No change |
| Novagold Resources NG · history | 0.4% | Q2 2013 or earlier | Add 13% |
| Theravance Biopharma TBPH.CV · convertible notes · history | 0.3% | Q4 2016 | No change |
| Cascadian Therapeutics CASC · history | 0.3% | Q2 2016 | No change |
| ChipMOS IMOS · history | 0.3% | Q2 2013 or earlier | Reduce 52% |
| Saban Capital Acquisition SCAC · history | 0.2% | Q4 2016 | No change |
| Sunrun RUN · history | 0.2% | Q3 2015 | No change |
| Sentinel Energy Services STNL.U · units · history | 0.2% | Q4 2017 | Buy |
| Forward Pharma FWP · history | 0.2% | Q4 2014 | Reduce 35% |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | No change |
| Orexigen Therapeutics OREX · history | 0.0% | Q3 2015 | No change |
| Saban Capital Acquisition SCAC.WS · warrants · history | 0.0% | Q4 2016 | No change |
| 34 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2017, adjusted for stock splits.
Sector weighting
| Media & telecom | 29.0% | |
|---|---|---|
| Energy | 22.9% | |
| Health care | 21.4% | |
| Financials & real estate | 17.0% | |
| Technology | 7.9% | |
| Industrials | 1.2% | |
| Materials | 0.5% |
What changed from Q3 2017
- Buy Time Warner TWX 7.3% of the 13F
- Buy Sentinel Energy Services STNL.U 0.2% of the 13F
- Add 16% Twenty-First Century Fox FOXA 6.3% → 7.6%
- Add 52% Allergan AGN 7.6% → 7.3%
- Add 22% Qorvo QRVO 7.9% → 7.2%
- Add 3% Antero Resources AR 5.9% → 4.6%
- Add 43% Twenty-First Century Fox FOX 2.4% → 3.6%
- Add 6822% Pioneer Natural Resources PXD 0.1% → 3.4%
- Add 102% Cardinal Health CAH 2.1% → 3.1%
- Add 172% McKesson MCK 1.0% → 2.1%
- Add 660% Cencora COR 0.2% → 1.3%
- Add 19% Veritiv VRTV 1.2% → 1.0%
- Add 40% AMC Entertainment AMC 0.7% → 0.7%
- Add 13% Novagold Resources NG 0.5% → 0.4%
- Reduce 31% PBF Energy PBF 5.4% → 3.8%
- Reduce 10% Express Scripts ESRX 2.0% → 1.7%
- Reduce 52% ChipMOS IMOS 0.7% → 0.3%
- Reduce 35% Forward Pharma FWP 0.5% → 0.2%
- Sell Dell Technologies DELL was 2.9%
- Sell Permian Resources CDEV was 0.5%
- Sell Avis Budget Group CAR was 0.5%
- Sell Silver Run Acquisition II SRUN was 0.3%
- Sell Simply Good Foods SMPL.WS was 0.0%